[HTML][HTML] Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli, V Di Sarno… - Scientific reports, 2021 - nature.com
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer.
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - europepmc.org
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - SCIENTIFIC …, 2021 - iris.unisa.it
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer.
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - search.ebscohost.com
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer.
M DI DONATO, C Ostacolo, P Giovannelli… - SCIENTIFIC …, 2021 - iris.unicampania.it
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
[HTML][HTML] Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - ncbi.nlm.nih.gov
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - ui.adsabs.harvard.edu
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - SCIENTIFIC …, 2021 - iris.unina.it
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - pubmed.ncbi.nlm.nih.gov
Transient receptor potential melastatin-8 (TRPM8) represents an emerging target in prostate
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
cancer, although its mechanism of action remains unclear. Here, we have characterized and …
[PDF][PDF] Therapeutic potential of TRPM8 antagonists in prostate cancer
M Di Donato, C Ostacolo, P Giovannelli… - Scientific …, 2021 - researchgate.net
Results In vitro pharmacological characterization. The molecular structure of tested
compounds is shown in Figure S1 (Supplementary Information). They were synthesized …
compounds is shown in Figure S1 (Supplementary Information). They were synthesized …